GRM7 and Neurodevelopmental delay: Pre-clinical studies in rodent models suggest that decreased mGlu7 function is sufficient to mimic phenotypes that correlate to NDD symptom domains and that positive modulation of mGlu7 activity can improve some deficits, specifically in a mouse model of RTT.